What is Bipolar Depression and How TMS Helps
Bipolar disorder affects about 4.4% of the U.S. population. Everyone knows about the mania. What most people don’t realize is how much time bipolar patients spend depressed. Research in the Archives of General Psychiatry found that people with bipolar I spend roughly three times as many weeks depressed as manic. For bipolar II, the ratio skews even further toward depression.
This creates a treatment problem that’s hard to overstate. Bipolar depression looks a lot like major depressive disorder on the surface — persistent sadness, fatigue, lost interest, difficulty concentrating, sleep disruption, sometimes suicidal thinking. But you can’t just throw antidepressants at it. Antidepressants carry a documented risk of flipping bipolar patients into mania or hypomania. This treatment-emergent affective switch (TEAS) happens in an estimated 10-25% of bipolar patients on antidepressants, depending on the medication and the bipolar subtype.
So what do you do when you’re deeply depressed but can’t safely take the most common depression treatments?
TMS offers a way through. Because it works through targeted electromagnetic stimulation of specific brain circuits — not systemic neurochemical changes — the risk of triggering mania appears substantially lower. Multiple studies report manic switch rates of only 1-3% with TMS, compared to much higher rates with antidepressants. For people trapped in treatment-resistant bipolar depression with limited safe medication options, that matters.
How TMS Works for Bipolar Depression
Brain Regions Targeted
The primary target is the dorsolateral prefrontal cortex (DLPFC), same as in unipolar depression. But the stimulation approach differs in important ways.
Standard depression protocols use high-frequency stimulation (10 Hz) on the left DLPFC to boost underactive circuits. For bipolar depression, many clinicians take a different route: low-frequency stimulation (1 Hz) on the right DLPFC. This inhibitory protocol reduces overactivity in the right prefrontal cortex and, through interhemispheric balance effects, indirectly bumps up left prefrontal activity. The low-frequency approach is considered safer because it’s less likely to produce the widespread cortical excitation that could theoretically trigger a manic switch.
Some providers do use the standard left-sided high-frequency protocol for bipolar patients, particularly those with bipolar II who have a lower baseline risk of full manic episodes. The choice depends on your history, bipolar subtype, and your clinician’s judgment.
Stimulation Parameters
- Frequency: 1 Hz (low-frequency, inhibitory) to the right DLPFC is the most conservative. Some protocols use 10 Hz to the left DLPFC or bilateral stimulation combining both.
- Intensity: 110-120% of motor threshold, though some clinicians start lower (100%) and ramp up.
- Pulses per session: 1,200-1,800 for low-frequency; 3,000 for high-frequency.
- Session duration: 20-40 minutes depending on protocol.
- Treatment course: 20-36 sessions over 4-6 weeks. Many clinicians lean longer for bipolar patients.
Why Low-Frequency Right DLPFC May Be Safer
The theory involves prefrontal asymmetry. The left prefrontal cortex handles approach-related emotions and positive affect. The right handles withdrawal-related emotions and negative affect. In depression, the balance tips toward right-sided dominance. Low-frequency right DLPFC stimulation reduces that overactivity without directly exciting the left hemisphere — a more gradual, controlled rebalancing. That gentler mechanism may explain the lower manic switching rates.
Clinical Evidence and Success Rates
TMS for bipolar depression is off-label — the pivotal FDA clearance trials specifically excluded bipolar patients. But a growing body of research supports it:
Key Studies:
- A 2019 meta-analysis in the Journal of Affective Disorders by McGirr et al., pooling 19 studies with 181 bipolar depression patients, found an overall response rate of about 40.3% and remission rate of 23.2%. The mania rate across all studies was only 2.2%.
- A randomized controlled trial by Tavares et al. (2017) in JAMA Psychiatry studied 50 bipolar depression patients. The active group showed significantly greater improvement, with response rates approaching 48%.
- A 2021 systematic review in Brain Stimulation found low-frequency right DLPFC stimulation produced response rates of 41-53% in bipolar depression, with manic switch rates consistently below 3%.
- Dell’Osso et al. (2019) in Psychiatry Research examined TMS as an add-on to mood stabilizers — the combination produced response rates 15-20 percentage points higher than mood stabilizers alone.
How that stacks up:
- Lamotrigine: ~40-50% response, but takes 6-8 weeks to reach therapeutic doses
- Quetiapine: ~55-60% response, but with significant metabolic side effects
- Lurasidone: ~50-55% response
- TMS: 40-50% response — competitive with medications but with a fundamentally different (and for many people, more tolerable) side effect profile
One reassuring finding: TMS can be safely combined with all major mood stabilizers. Lithium, valproate, lamotrigine, and carbamazepine don’t interfere with TMS efficacy, and TMS doesn’t alter mood stabilizer blood levels. This matters because mood stabilizers should almost never be stopped when adding TMS — the combination is both safer and more effective.
Who Qualifies for TMS Treatment
TMS for bipolar depression may be appropriate if:
Strong Candidates:
- Confirmed bipolar I or bipolar II with prominent depressive episodes
- Inadequate response to at least one mood stabilizer at therapeutic doses
- History of treatment-emergent mania or hypomania with antidepressants
- Currently maintained on a mood stabilizer with psychiatrist support for adding TMS
- Treatment-resistant bipolar depression (at least two adequate medication trial failures)
Potential Candidates:
- Want to avoid atypical antipsychotics due to weight gain, metabolic syndrome, or sedation concerns
- Bipolar depression with prominent anxiety features (some studies suggest right-sided TMS works particularly well here)
- Prolonged depressive episode not responding to medication adjustments over 8-12 weeks
Who Should Not Receive TMS:
- Metallic implants in or near the head (standard dental work excepted)
- History of seizures unrelated to bipolar disorder
- Currently in a manic or hypomanic episode — TMS should only start during the depressive phase
- Not taking a mood stabilizer (most clinicians consider this an essential safety requirement)
- Unstable rapid cycling with frequent, unpredictable mood shifts
What to Expect During Treatment
Before Treatment Begins
Your TMS provider will do a thorough evaluation: psychiatric assessment confirming the bipolar diagnosis and current depressive episode, review of your medication history and mood stabilizer regimen, baseline mood ratings using standardized scales (MADRS and YMRS), and a discussion of the off-label nature of treatment.
The First Session
The technician determines your motor threshold — the minimum pulse intensity to make your thumb twitch. This takes about 15-20 minutes and personalizes treatment to your brain. The coil then gets positioned over the target area using measurements from your motor cortex.
Ongoing Sessions
Each session: 20-40 minutes. You sit in a reclining chair while the coil delivers pulses. Low-frequency protocols produce a steady clicking at one pulse per second. High-frequency protocols come in rapid bursts. Most people read, listen to podcasts, or zone out.
Mood Monitoring
This is where bipolar TMS differs most from standard depression protocols. Your provider assesses your mood at every session, watching specifically for early hypomania signs: decreased need for sleep, increased energy or goal-directed activity, pressured speech, elevated or irritable mood, grandiosity. Sleep logs are often used as an early warning system — reduced sleep is frequently the first signal. If anything concerning shows up, treatment pauses and your psychiatrist gets involved immediately.
Timeline for Improvement
Most people notice improvement after 2-3 weeks (10-15 sessions). Full benefits typically arrive by the end of the 4-6 week course. Some need an additional 1-2 weeks of taper sessions to lock in gains.
Side Effects and Safety
Common Side Effects
- Scalp discomfort or mild pain at the stimulation site: 30-40% of patients, usually fading over the first week
- Mild headache: About 20-30%, usually responsive to OTC pain relievers
- Lightheadedness: Occasional, resolving within minutes
Rare but Important Risks
- Treatment-emergent mania or hypomania: 1-3% of bipolar patients — significantly lower than the 10-25% rate with antidepressants. When it occurs, it’s typically mild and resolves when TMS stops and mood stabilizer doses adjust.
- Seizure: Extremely rare (less than 0.1%). No higher in bipolar patients than the general TMS population when proper protocols are followed.
Safety Compared to Medication Options
TMS avoids the metabolic side effects of atypical antipsychotics (weight gain averaging 2-7 kg, blood sugar elevation, cholesterol changes), the cognitive dulling sometimes tied to mood stabilizers, sexual dysfunction common with psychiatric medications, and serotonin syndrome risk when combining antidepressants with other serotonergic drugs. For people who’ve struggled with medication tolerability, that profile is a big draw.
TMS Devices Used for Bipolar Depression
Several systems are used, though none hold specific FDA clearance for bipolar depression:
- NeuroStar TMS Therapy System: Most widely available in the U.S. Figure-8 coil, FDA-cleared for MDD, most commonly used off-label for bipolar depression.
- MagVenture MagPro: Both standard and deep coil options. Flexible programming for low-frequency right DLPFC protocols optimized for bipolar patients.
- BrainsWay Deep TMS: H-coil helmet stimulating deeper and broader brain regions. Some clinicians prefer this for bipolar depression because the broader field may engage more mood-regulating circuitry.
- Nexstim NBS System: MRI-guided targeting for precise coil placement — potentially valuable for bipolar depression where accurate DLPFC targeting is critical for both efficacy and safety.
The device matters less than the clinician operating it. A skilled provider using any of these systems with appropriate bipolar-specific protocols can deliver effective treatment.
Cost and Insurance Coverage
Typical Costs
A full course runs $6,000-$15,000 without insurance. The range reflects geography, provider, and course length. Bipolar patients often need longer courses (30-36 sessions rather than the standard 20-30 for unipolar depression), which drives up the total.
Insurance Coverage Challenges
Getting coverage for bipolar depression TMS is harder than for unipolar depression:
- Many policies limit TMS coverage to FDA-cleared indications, which currently doesn’t include bipolar depression
- Some insurers require documentation of failed medication trials — but their lists may include antidepressants that are actually contraindicated in bipolar disorder
- Prior authorization demands extensive documentation of treatment resistance
Strategies That Work
- Work with an experienced provider: Clinics that regularly treat bipolar patients have established authorization and appeals processes
- Request a peer-to-peer review: When denied, your psychiatrist can talk directly to the insurer’s medical director to present the clinical case
- Document everything: All medications tried, doses, duration, reasons for stopping, outcomes
- Appeal denials: First-round denials are common but not final. Many patients get coverage on appeal, especially with supporting literature
Financing Options
Many clinics offer payment plans, medical financing through CareCredit or Prosper Healthcare Lending, and sliding-scale fees. Some offer reduced rates for patients joining research studies.
Finding a TMS Provider for Bipolar Depression
What to Look For
Not every TMS clinic can safely treat bipolar depression. When evaluating providers, ask:
- How many bipolar patients have you treated with TMS? Look for at least 20-30. This condition requires specific expertise.
- What protocol do you use for bipolar depression? They should be able to explain their rationale for choosing right-sided low-frequency vs. left-sided high-frequency, or bilateral.
- How do you monitor for manic switching? Expect standardized mood rating scales at every session, sleep tracking, and a clear protocol for what happens if hypomania signs appear.
- Do you require a concurrent mood stabilizer? Most experienced providers consider this essential. A provider willing to treat bipolar depression without mood stabilization may not fully appreciate the risks.
- Is a psychiatrist directly involved? TMS for bipolar depression needs close psychiatric oversight — not just a technician running pulses.
Using the TMS Provider Directory
Our directory lets you search by location and filter for bipolar experience. When you contact a provider, mention your bipolar diagnosis upfront — this lets them confirm they have the right expertise and protocols before scheduling your consultation.
Frequently Asked Questions
Can TMS replace my mood stabilizer?
No. TMS for bipolar depression is an add-on to mood stabilizer therapy, not a replacement. Stopping your mood stabilizer to try TMS alone significantly increases the risk of mood destabilization, including manic switching. The published evidence supporting TMS in bipolar depression is almost entirely based on patients who stayed on their mood stabilizers throughout.
Is TMS for bipolar depression FDA-approved?
TMS is not FDA-cleared specifically for bipolar depression. It’s used off-label — your provider is applying a legally marketed device for an indication that hasn’t gone through the FDA clearance process. Off-label use is common in psychiatry and is backed by growing evidence, but it does affect insurance coverage and means fewer standardized treatment guidelines exist.
How does the risk of manic switching with TMS compare to antidepressants?
Studies report 1-3% with TMS vs. 10-25% with antidepressants (the rate varies by class — tricyclics carry the highest risk, SSRIs somewhat lower). No treatment carries zero risk of triggering mania in bipolar patients, but TMS appears to be among the safest options for addressing the depressive phase.
How long do the benefits last?
Varies by person. Some maintain improvement for 6-12 months or longer. Others see depressive symptoms return after 3-6 months. Maintenance sessions — typically one every 2-4 weeks — can extend the benefit. Your provider will build a maintenance plan based on your response.
Can I receive TMS if I’m in a mixed episode?
Mixed episodes add complexity. Most providers prefer to treat during a clearly defined depressive episode rather than a mixed state, because the manic features could potentially be worsened by stimulation. If you’re experiencing mixed features, talk to your psychiatrist first. Stabilizing the manic component with medication adjustments is typically recommended before starting TMS for the depressive symptoms.